Steve Valiquette
Stock Analyst at Barclays
(2.25)
# 1,485
Out of 4,667 analysts
177
Total ratings
44.94%
Success rate
-5.55%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.93 | +34.38% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $8.29 | -3.50% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $615.65 | +0.06% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.24 | +112.26% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $4.13 | +21.07% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.33 | +130.95% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.66 | +35.90% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $55.77 | +54.20% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $57.81 | +47.03% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $335.11 | -10.48% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $90.00 | -2.22% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $38.57 | -11.85% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $153.35 | -31.53% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $64.25 | -14.40% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.57 | -29.99% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $196.79 | -27.84% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $22.27 | -77.55% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $99.10 | -42.48% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $138.18 | -40.66% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $21.40 | -15.89% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $40.15 | -22.79% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $282.50 | +32.74% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $31.08 | -38.87% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $5.20 | +34.62% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $277.78 | +105.20% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $29 | $14.31 | +102.66% | 2 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $118.33 | -45.91% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $322.50 | -3.88% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $577.00 | -2.08% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $5.21 | +4,506.53% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $11.24 | +567.26% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $4.78 | +297.49% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.81 | +162.47% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $22.30 | +52.47% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $5.80 | +244.83% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $137.92 | +88.52% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.93
Upside: +34.38%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $8.29
Upside: -3.50%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $615.65
Upside: +0.06%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.24
Upside: +112.26%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $4.13
Upside: +21.07%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.33
Upside: +130.95%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.66
Upside: +35.90%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $55.77
Upside: +54.20%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $57.81
Upside: +47.03%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $335.11
Upside: -10.48%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $90.00
Upside: -2.22%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.57
Upside: -11.85%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $153.35
Upside: -31.53%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $64.25
Upside: -14.40%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.57
Upside: -29.99%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $196.79
Upside: -27.84%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $22.27
Upside: -77.55%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $99.10
Upside: -42.48%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $138.18
Upside: -40.66%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $21.40
Upside: -15.89%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $40.15
Upside: -22.79%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $282.50
Upside: +32.74%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $31.08
Upside: -38.87%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $5.20
Upside: +34.62%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $277.78
Upside: +105.20%
Jun 29, 2022
Reinstates: Overweight
Price Target: $29
Current: $14.31
Upside: +102.66%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $118.33
Upside: -45.91%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $322.50
Upside: -3.88%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $577.00
Upside: -2.08%
Nov 11, 2021
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $5.21
Upside: +4,506.53%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $11.24
Upside: +567.26%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $4.78
Upside: +297.49%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.81
Upside: +162.47%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $22.30
Upside: +52.47%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $5.80
Upside: +244.83%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $137.92
Upside: +88.52%